Comprehensive Retatrutide
Dose Protocol Framework
| Protocol Phase | Experimental Target Dose | Duration / Interval | Research Focus & Observational Endpoints |
| Initial Baseline | 2.0 mg weekly | Weeks 1 – 4 | Assessing baseline GI tolerance and initial metabolic response. |
| Phase I Titration | 4.0 mg weekly | Weeks 5 – 8 | Step-up evaluation; observing early glucose and lipolysis changes. |
| Phase II Titration | 8.0 mg weekly | Weeks 9 – 12 | Intermediate scaling to measure multi-receptor activation synergy. |
| Maintenance Phase | 9.0 mg – 12.0 mg weekly | Weeks 13+ | Maximum protocol concentration for long-term endpoint trials. |
To preserve the delicate tertiary structure of the C-10 peptide during preparation
Reagent Selection: Reconstitute using sterile Bacteriostatic Water (0.9% Benzyl Alcohol) to ensure solution preservation over multi-dose trials. Retatrutide dosing guide
Gentle Dilution: Inject 1.0 mL to 2.0 mL of solvent slowly down the inner glass wall of the vial. Retatrutide dosing guide
Avoid Agitation: Allow the powder to dissolve naturally or gently swirl the vial. Never shake the vial vigorously, as shearing forces can denature peptide chains.
Refrigerated Storage: Maintain reconstituted solution at 2°C to 8°C (36°F to 46°F) protected from direct light exposure.